Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2006-04-04
2006-04-04
Azpuru, Carlos A. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S464000, C424S465000
Reexamination Certificate
active
07022340
ABSTRACT:
The present invention relates to a novel pharmaceutical composition as a solid dosage form comprising desmopressin as a therapeutically active ingredient, and to a method for manufacturing thereof. The invention relates to a pharmaceutical composition as a solid dosage form comprising desmopressin, or a pharmaceutically acceptable salt thereof, as a therapeutically active ingredient together with a pharmaceutically acceptable excipient, diluent or carrier, or mixture thereof; wherein the pharmaceutical composition is composed of a compressed granulate and contains lubricant in an amount of from 0.05 to less than 0.50 percent by weight of said pharmaceutical composition.
REFERENCES:
patent: 4675188 (1987-06-01), Chu
patent: 4820627 (1989-04-01), McGeehan
patent: 5047398 (1991-09-01), Hagstam et al.
patent: 2002/0122817 (2002-09-01), Gabel et al.
patent: 2003/0091637 (2003-05-01), Petereit et al.
patent: 2003/0175214 (2003-09-01), Staniforth et al.
patent: 2003/0185764 (2003-10-01), Staniforth et al.
patent: 2004/0220080 (2004-11-01), Lomryd et al.
patent: 0 752 877 (2000-07-01), None
patent: 0 710 122 (2001-12-01), None
patent: 1 255 557 (2002-11-01), None
patent: WO 95/18602 (1995-07-01), None
patent: WO 97/15297 (1997-05-01), None
patent: WO 97/23485 (1997-07-01), None
patent: WO 00/9423 (2000-10-01), None
patent: WO 01/78694 (2001-10-01), None
patent: WO 01/78695 (2001-10-01), None
patent: WO 01/78696 (2001-10-01), None
patent: WO 01/82906 (2001-11-01), None
patent: WO 02/00197 (2002-01-01), None
patent: WO 03/094886 (2003-11-01), None
Robert O. Williams III et al., “Compaction Properties of Microscrystalline Cellulose and Sodium Sulfathiazole in Combination with Talc or Magnesium Stearate”, Journal of Pharmaceutical Sciences, vol. 78, No. 12, Dec. 1989, pp. 1025-1034.
“Pharmaceutical Dosage Forms: Tablets”; vol. 1, pp. 297-298, H.A. Lieberman et al., New York & Basel, 1989.
“Pharmaceutical Dosage Forms: Parenteral Medications”, vol. 3, pp. 27-29, H.A. Lieberman et al., New York & Basel, 1990.
“Pharmaceutics—The Science of Dosage Form Design”, pp. 625-627, M.E. Aulton et al., Edinburgh, London, Melbourne & New York, 1988.
“Handbook of Pharmaceutical Excipients”, Ed. A.H. Kibble, 3rdEd., American Pharmaceutical Assocation, USAS and Pharmaceutical Press UK 2000.
N.A. Armstrong; “Tabletting”, Pharmaceutics—The Science of Dosage Form Design, pp. 647-668, 1988.
Lomryd Hakan
Nicklasson Helena
Olsson Lars-Erik
Azpuru Carlos A.
Ferring B.V.
LandOfFree
Pharmaceutical composition as solid dosage form and method... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition as solid dosage form and method..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition as solid dosage form and method... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3573683